NCT00050141View on ClinicalTrials.gov

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2005

Study Completion Date

January 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

ZARNESTRA, tipifarnib, R115777

Trial Locations (23)

Unknown

Miami

Chicago

Durham

Cleveland

Fort Worth

Tyler

Brussels

Leuven

Bordeaux

Clermont-Ferrand

Montpellier Cedex 5 N/A

Rennes

Saint-Herblain

Vandœuvre-lès-Nancy

The Hague

Moscow

Saint Petersburg

Huddersfield

Leeds

London

Manchester

Newcastle upon Tyne

Sutton

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00050141 - Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer | Biotech Hunter | Biotech Hunter